Switch theme
Sign up to access all valuation multiples
The Searle Co Ltd is a pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical and other consumer products. The company manufactures pharmaceutical products like Hydryllin, Extor, Nuberol, Forte, Peditral, Selanz SR, Tramal, and other products. Its pharmaceutical product range covers the therapeutic areas of cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care.
1965
3.0K+
Last FY Revenue $104M
Last FY EBITDA $20.3M
$188M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Searle Co. achieved revenue of $104M and an EBITDA of $20.3M.
Searle Co. expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Searle Co. valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $104M | XXX | XXX | XXX |
| Gross Profit | XXX | $48.7M | XXX | XXX | XXX |
| Gross Margin | XXX | 47% | XXX | XXX | XXX |
| EBITDA | XXX | $20.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 19% | XXX | XXX | XXX |
| EBIT | XXX | $15.5M | XXX | XXX | XXX |
| EBIT Margin | XXX | 15% | XXX | XXX | XXX |
| Net Profit | XXX | -$8.4M | XXX | XXX | XXX |
| Net Margin | XXX | -8% | XXX | XXX | XXX |
| Net Debt | XXX | $45.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Searle Co.'s stock price is PKR 89 (or $0).
Searle Co. has current market cap of PKR 45.5B (or $162M), and EV of PKR 53.1B (or $188M).
See Searle Co. trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $188M | $162M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Searle Co. has market cap of $162M and EV of $188M.
Searle Co.'s trades at 1.8x EV/Revenue multiple, and 9.4x EV/EBITDA.
Equity research analysts estimate Searle Co.'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Searle Co.'s P/E ratio is not available.
See valuation multiples for Searle Co. and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $162M | XXX | $162M | XXX | XXX | XXX |
| EV (current) | $188M | XXX | $188M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 9.4x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 11.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -89.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 32.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSearle Co.'s revenue per employee in the last FY averaged $34K, while opex per employee averaged $11K for the same period.
Searle Co.'s rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Searle Co.'s rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Searle Co. and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $34K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $11K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 32% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Searle Co. acquired XXX companies to date.
Last acquisition by Searle Co. was XXXXXXXX, XXXXX XXXXX XXXXXX . Searle Co. acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Searle Co. founded? | Searle Co. was founded in 1965. |
| Where is Searle Co. headquartered? | Searle Co. is headquartered in Pakistan. |
| How many employees does Searle Co. have? | As of today, Searle Co. has 3.0K+ employees. |
| Is Searle Co. publicy listed? | Yes, Searle Co. is a public company listed on KAR. |
| What is the stock symbol of Searle Co.? | Searle Co. trades under SEARL ticker. |
| Who are competitors of Searle Co.? | Similar companies to Searle Co. include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Searle Co.? | Searle Co.'s current market cap is $162M |
| Is Searle Co. profitable? | Yes, Searle Co. is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
